Selank vs Semax

TL;DR

• Selank is a synthetic analog of tuftsin. Studied primarily for anxiolytic (anxiety-reducing) effects via GABAergic and serotonergic pathways.
• Semax is a synthetic fragment of ACTH(4-10). Studied primarily as a nootropic, with effects on BDNF and NGF, attention, and recall.
• The shorthand: Selank for calm, Semax for focus. They're often used together because they target different systems.

If you only remember one thing: these aren't competing nootropics. Selank is closer to an anxiolytic. Semax is closer to a focus/recall enhancer. Different jobs.

The headline difference, in one sentence

Selank takes the anxiety down. Semax turns the focus up.

What each one is

Both peptides are unusually well-tolerated in the published research and have a long history of clinical use in Russia.

Pick Selank if...

• The research target is anxiety, stress response, or generalized arousal regulation.
• You want effects similar to a benzodiazepine without the sedation, dependence profile, or cognitive blunting.
• You're researching immune-mood interactions — Selank has documented effects on cytokine balance.
• You want a peptide with GABAergic mechanism that doesn't directly bind GABA receptors.

Pick Semax if...

• The research target is focus, attention, or memory consolidation.
• You're researching neurogenesis, BDNF, or NGF signaling specifically.
• You want a compound studied in stroke recovery and neuroprotection literature.
• You're looking for a "clear-headed cognitive lift" rather than a stimulant feel.

Why people often use both

The two peptides target different systems but converge on overall mental performance:

• Selank lowers the anxiety baseline so you can think.
• Semax sharpens the focus on what you're thinking about.

Combined, the research suggests an additive effect: lower stress, higher cognitive engagement. There's no significant pharmacological conflict between them.

The N-acetylated versions (NA-Selank, NA-Semax) extend the duration of action through resistance to enzymatic breakdown, generally giving longer effect from a single intranasal dose.

Honest tradeoffs

• Subjective vs objective effects: a lot of the existing reports are subjective. Objective controlled-trial data exists, mostly Russian-language, with measurement methods that don't always translate to Western clinical standards.
• Intranasal delivery: both are typically administered intranasally. This requires precise volume control and good technique — most users dose with measured pipette or insulin syringe (no needle) for accuracy.
• Reconstitution sensitivity: peptides are stable for short periods refrigerated; degraded by warm storage and freeze-thaw cycles.
• Acute vs chronic effect: acute single doses produce noticeable effects. Most research protocols use chronic dosing (1–4 weeks) for cumulative effects on mood or cognition baseline.
• No "stack with everything" promise: Selank/Semax are not magic enhancers for arbitrary other peptides. They're well-characterized within their own research category.

Quick decision shortcut

Where to read more

• Full breakdown of Selank and the longer-acting NA-Selank.
• Full breakdown of Semax and the longer-acting NA-Semax.

Important context

Selank and Semax are approved for clinical use in Russia (where they were developed) but are not FDA-approved in the United States. Most published research is from Russian-language journals or limited Western pre-clinical studies. Nothing on this page is medical advice.